Description
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Product Unit Size | Cost | Quantity | Stock |
---|
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Cas No. | 354813-19-7 |
---|---|
Purity | ≥98% |
Formula | C23H33N5O2 |
Formula Wt. | 411.55 |
IUPAC Name | N-{1-[(Cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propyl-1-piperazinyl)benzamide |
Synonym | AAE-581 |
Solubility | DMSO: ≥ 46 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Jerome C, Missbach M, Gamse R. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys. Osteoporos Int. 2012 Jan;23(1):339-49. PMID: 21380636.
Chappard D, Libouban H, Mindeholm L, et al. The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients. Microsc Res Tech. 2010 Jul;73(7):726-32. PMID: 20025055.
B-Raf and c-Raf inhibitor.
BTK and IL-2-inducible kinase inhibitor.
CHK1 inhibitor.
Synthesis intermediate
Thiazolidine; Pim kinase inhibitor.
Cyclic sesquiterpene found in ginger root; pote...
Akt inhibitor.
Peptide, involved in neutrophil activation; FPR...
PRMT5/MTA complex inhibitor
Fluoroquinolone; topoisomerase IV and bacterial...
Ca2+ sensitizer; ATP-sensitive K+ channel activ...
Found in Salvia; fatty acid synthase and AChE i...
Purine derivative; CDK inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Akt inhibitor.
ALK inhibitor.
EGFR and PDGFR inhibitor
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Diterpene found in coffee beans.
Macrolide; protein translation inhibitor, mamma...